LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EQUITY FLASH L impact Sep 28, 2026, 11:32 AM UTC

Air Canada completes $800 million substantial issuer bid

The company says the issuer bid has been completed.

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

AC.TO

Related stories

Fuller Names Bailly to Board H.B. Fuller Company NYSE:FUL shares stumbled Monday, as the world’s largest pureplay adhesives company announced the appointment of R. Jeffrey Bailly to its Board of Directors, eff L impact | EQUITY | Sep 28, 2026, 02:18 PM UTC SCHW login down Reports say SCHW login is down. M impact | EQUITY | Sep 28, 2026, 02:16 PM UTC Vox Royalty to buy 0.75% Sorby Hills royalty for $13 million The royalty is on Sorby Hills in Western Australia and is held by a private seller. Closing is expected in Q4 2026, subject to customary conditions and Australia’s Foreign Investme M impact | EQUITY | Sep 28, 2026, 02:16 PM UTC This Biotech Company Added Nearly $3B To Its Market Cap Today — Here’s Why KOD Stock Is Ripping Today Shares of Kodiak Sciences (KOD) more than doubled after the opening bell on Monday as both of its experimental therapies met the primary goal of a Phase 3 study in patients with we L impact | EQUITY | Sep 28, 2026, 02:14 PM UTC Verizon to report third-quarter earnings Oct. 26, 2026 Verizon said it will report third-quarter earnings on Oct. 26, 2026. M impact | EQUITY | Sep 28, 2026, 02:14 PM UTC Kodiak Sciences Shares Hit 52-Week High After Positive Phase 3 Trial By Chris WackKodiak Sciences shares more than doubled Monday after the company said its Phase 3 study for Zenkuda and tabirafusp-ted met the primary endpoints for both drugs in pat L impact | EQUITY | Sep 28, 2026, 02:13 PM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.